Galecteye Pharma ApS
CVR number: 38248243
Ole Maaløes Vej 3, 2200 København N
consulting@schambye.dk
tel: 26373726
Income statement (kDKK)
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -17.11 | -10.04 | -5.00 | -6.25 |
| EBIT | -17.11 | -10.04 | -5.00 | -6.25 |
| Other financial expenses | -1.05 | -1.01 | -1.02 | -1.03 |
| Pre-tax profit | -18.15 | -11.05 | -6.02 | -7.28 |
| Net earnings | -18.15 | -11.05 | -6.02 | -7.28 |
Assets (kDKK)
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Short term receivables total | ||||
| Cash and bank deposits | 142.26 | 130.35 | 124.10 | 117.85 |
| Cash and cash equivalents | 142.26 | 130.35 | 124.10 | 117.85 |
| Balance sheet total (assets) | 142.26 | 130.35 | 124.10 | 117.85 |
Equity and liabilities (kDKK)
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -18.15 | -29.20 | -35.22 | |
| Profit of the financial year | -18.15 | -11.05 | -6.02 | -7.28 |
| Shareholders equity total | 31.85 | 20.80 | 14.78 | 7.50 |
| Non-current loans from credit institutions | 101.04 | 102.05 | 103.07 | 104.10 |
| Non-current liabilities total | 101.04 | 102.05 | 103.07 | 104.10 |
| Other non-interest bearing current liabilities | 9.38 | 7.50 | 6.25 | 6.25 |
| Current liabilities total | 9.38 | 7.50 | 6.25 | 6.25 |
| Balance sheet total (liabilities) | 142.26 | 130.35 | 124.10 | 117.85 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.